martes, 8 de enero de 2019

Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments | BMC Cancer | Full Text

Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments | BMC Cancer | Full Text



BMC Cancer

Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments

  • Email author,
  • ,
  • ,
  • ,
  • ,
  • ,
  • ,
  •  and
  • View ORCID ID profile
BMC Cancer201919:32
  • Received: 28 June 2018
  • Accepted: 11 December 2018
  • Published: 
Open Peer Review reports

Abstract

Background

The Symptom Screening in Pediatrics Tool (SSPedi) is valid for assessing symptoms in children aged 8–18 years receiving cancer treatments. The objective was to develop a new self-report symptom screening tool for children receiving cancer treatments who are 4–7 years of age (mini-SSPedi), based on SSPedi.

Methods

Respondents were children with cancer or pediatric hematopoietic stem cell transplantation (HSCT) recipients who were 4–7 years of age. We included the same 15 symptoms contained in SSPedi. Using cognitive interviewing, we developed mini-SSPedi in three phases and made decisions based upon respondent understanding. First, we developed questionnaire structure regarding recall period, concept of bother and response option format. Second, we determined wording of each symptom. Third, we evaluated the entire mini-SSPedi instrument for understanding and ease of completion.

Results

We enrolled 100 participants in total and included 30, 40 and 30 in each of the three phases. Questionnaire structure was satisfactory with a recall period of “today” and a faces-based 3-point Likert scale. Bother was well-understood. Five symptoms required modification to achieve satisfactory understanding while the remaining 10 SSPedi symptoms did not require modification. Among the last 10 children enrolled, all understood each mini-SSPedi item and none thought mini-SSPedi was hard to complete.

Conclusion

We developed a symptom screening tool for children with cancer and pediatric HSCT recipients between 4 and 7 years of age that is understandable and easy to complete. Future work will evaluate the psychometric properties of mini-SSPedi and develop an electronic version of the instrument.

Keywords

  • Symptom screening
  • Children
  • Self-report
  • Cancer
  • Hematopoietic stem cell transplantation

No hay comentarios:

Publicar un comentario